Biosynthesis of the v-sis gene product: signal sequence cleavage, glycosylation, and proteolytic processing.

AUTOR(ES)

Hannink, M

RESUMO

The v-sis oncogene and its cellular homolog c-sis encode chain B of platelet-derived growth factor. Cells transformed by v-sis produce a platelet-derived growth factor-related molecule which is able to stimulate the platelet-derived growth factor receptor in an autocrine fashion. Site-directed mutagenesis was used to construct several mutations which substitute charged residues for hydrophobic residues in the proposed signal sequence of the v-sis gene product. Two of these mutations resulted in the synthesis of altered v-sis gene products with an unexpected nuclear location and a loss of biological activity. We also report here the intracellular localization of the v-sis gene product to the endoplasmic reticulum-Golgi compartment, where signal sequence cleavage and N-linked glycosylation occur. The v-sis gene product contains no transmembrane regions, as it is completely protected within isolated microsomes from trypsin proteolysis. Site-directed mutagenesis was also used to alter a proposed proteolytic processing site in the v-sis gene product. This mutant v-sis gene, which encodes Asn-Ser in place of Lys-Arg at residues 110 to 111, was found to retain full biological activity.

Documentos Relacionados

• In vitro mutagenesis of the v-sis transforming gene defines functional domains of its growth factor-related product.
• Platelet-derived growth factor agonist activity of a secreted form of the v-sis oncogene product.
• Deletions in the C-terminal coding region of the v-sis gene: dimerization is required for transformation.
• Deletions in the N-terminal coding region of the v-sis gene: determination of the minimal transforming region.
• Isolation and sequencing of a cDNA clone homologous to the v-sis oncogene from human endothelial cells.